Signal #114189 · SEC 8-K

$IDYA SEC Filing Alert & Real-Time AI Stock Impact Analysis

Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).

FAQ: $IDYA filing catalyst

Why did $IDYA trigger an AI stock catalyst alert?

$IDYA triggered a Stock Catalyst AI alert on 2026-11-03 00:00:00 UTC for a SEC 8-K filing (AI Score: +1.5/10). Headline: IDEAYA Biosciences Reports Q3 Results, Completed NDA Submission for Darovasertib. Key points: - Completed NDA submission in Q3 2026 for darovasertib plus crizotinib in metastatic uveal melanoma. - Balance sheet holds $1.15B in cash, cash equivalents, and marketable securities; runway guidance unchanged into 2030. - Q3 net loss expanded to $125.7M ($1.22/share) vs $112.5M in prior quarter.

How did $IDYA stock react after the SEC filing?

After the SEC 8-K for $IDYA, observed market reaction: T0 price $31.64; 4h move +0.57%. Past moves do not guarantee future results.

Where can I get real-time $IDYA SEC filing alerts?

Stock Catalyst AI pushes real-time SEC 8-K alerts for $IDYA via Telegram and the VIP Web Terminal from €10/month.

$IDYA

$IDYA – IDEAYA Biosciences Reports Q3 Results, Completed NDA Submission for Darovasertib

IDEAYA Biosciences, Inc.

2026-11-03 00:00:00 UTC · SEC 8-K · All $IDYA

Unlocked archive · Analyzed in <2s at T0

Bullish AI Sentiment (+1.5 / 10)

Completed NDA submission in Q3 2026 for darovasertib plus crizotinib in metastatic uveal melanoma.
Balance sheet holds $1.15B in cash, cash equivalents, and marketable securities; runway guidance unchanged into 2030.
Q3 net loss expanded to $125.7M ($1.22/share) vs $112.5M in prior quarter.

Observed market reaction after signal

4h +0.57%

Unlock Live VIP Terminal & Telegram – €10/mo Original filing →